skip to main content
Centre for Health Economics and Policy Analysis
Jillian Kohler

Jillian Kohler

Director, WHO Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector
Associate Member of the Centre for Health Economics and Policy Analysis, McMaster University
Associate Professor, Leslie Dan Faculty of Pharmacy,Munk School of Global & Dalla Lana School of Public Health, University of Toronto

T: (416) 946-8708

University of Toronto Leslie Dan Faculty of Pharmacy
144 College Street
Toronto, ON, M5S 3M2

Research website:

Jillian Kohler is Director, WHO Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector and an Associate Professor at the University of Toronto’s Leslie Dan Faculty of Pharmacy, Munk School of Global Affairs and Dalla Lana School of Public Health. She holds a PhD in politics from New York University and a MA and BA in Political Science from McGill University. Prior to joining the University of Toronto, she spent over a decade working in the field and in Headquarters on pharmaceutical policy for UNICEF, the World Bank and the World Health Organization. Her research and teaching focus on global pharmaceutical policy issues including good governance in the pharmaceutical system, access to medicines in failed states, and fair access to pharmaceutical treatment.


  • Corruption in the pharmaceutical sector
  • Social, ethical and legal issues surrounding drug access
  • Role of the State in pharmaceutical supply


Kohler J, Martinez MG. Participatory health councils and good governance: healthy democracy in Brazil? International Journal for Equity in Health. 2015. 14:21.

Moscou K, Kohler JC, Lexchin J. Drug Safety and Corporate Governance. Journal of Global Health Governance. June 2014.

Mackey TK, Liang BA, Kohler JC, Attaran A. Health Domains for Sale: The Need for Global Health Internet Governance. Journal of Medical Internet Research. 2014. 16(3):e62.

Kohler JC, Mackey TK, Ovtcharenko N. Why the MDGs need good governance in pharmaceutical systems to promote global health. BMC Public Health. 2014, 14:63.

Gabble R, Kohler JC. To patent or not to patent? The case of Novartis’ cancer drug Glivec in India.  BioMed Central. 2014: 10:3.

Kohler JC, Makady A. Harnessing Global Health Diplomacy to Curb Corruption in Health. Journal of Health Diplomacy. 2013. 1(1). 

Kohler JC, Pavignani E, Michael M, Ovtcharenko N, Murru M, Hill PS. An examination of pharmaceutical systems in severely disrupted countries. BMC International Health and Human Rights. 2012. 12:34.

Forman L, Kohler JC. (eds). Access to Medicines as a Human Right: What are the Implications for Pharmaceutical Industry? University of Toronto Press. 2012.

Kohler JC, Baghdadi G. "Good Governance in the Pharmaceutical Sector” in World Medicines Situation Report. World Health Organization. Geneva 2011.

Kohler JC. Mapping of Good Practices of Anti-Corruption Interventions in the Health Sector. Paper prepared for the UNDP Democratic Governance Group, New York, October 2011.

Kohler JC, Lexchin J, Kuek V, Orbinski J. Canada’s Access to Medicines Regime: Failure of Humanitarian Effort? Healthcare Policy. 2010. 5(3).

Kohler JC, Perez CA, Yeh S. Canada's Access to Medicines Regime: A Present Failure or A Future Success? Journal of Pharmaceutical Health Services Research. 2010. 1(1).


  • Global pharmaceutical policy
  • Health systems and society
All people
Please send questions, comments or suggestions to the Webmaster ( ).
Please review our Copyright Disclaimer policy

Interactive Marketing | Cubicle Fugitive